Kering SA (OTCMKTS:PPRUY – Get Free Report) saw a significant growth in short interest in June. As of June 30th, there was short interest totaling 189,301 shares, a growth of 191.9% from the June 15th total of 64,854 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 1,721,041 shares, the short-interest ratio is presently 0.1 days.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on the company. Barclays upgraded Kering from a “strong sell” rating to a “hold” rating in a research report on Monday, May 11th. Zacks Research raised Kering from a “strong sell” rating to a “hold” rating in a research note on Monday, May 25th. HSBC cut Kering from a “buy” rating to a “hold” rating in a report on Tuesday, April 21st. Finally, TD Cowen reissued a “buy” rating on shares of Kering in a report on Thursday, April 9th. Two investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold”.
Read Our Latest Research Report on Kering
Kering Stock Performance
About Kering
Kering is a global luxury goods group headquartered in Paris that designs, produces and distributes high-end fashion, leather goods, jewelry and watches. The company owns and manages a portfolio of well-known maisons — including Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen and several specialist jewelry and watchmakers — and supports those brands with centralized services for sourcing, manufacturing oversight, distribution and retail operations.
Originally part of a broader retail conglomerate, the group repositioned itself over the past two decades as a focused luxury house and adopted the Kering name in the 2010s.
Further Reading
- Five stocks we like better than Kering
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
Receive News & Ratings for Kering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kering and related companies with MarketBeat.com's FREE daily email newsletter.
